126 related articles for article (PubMed ID: 9642436)
21. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.
Andrews CP; Martin BG; Jacobs RL; Mohar DE; Diaz JD; Amar NJ; Kaiser HB; Vandewalker ML; Bernstein J; Toler WT; Prillaman BA; Dalal AA; Lee LA; Philpot EE
Allergy Asthma Proc; 2009; 30(2):128-38. PubMed ID: 19463203
[TBL] [Abstract][Full Text] [Related]
22. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
23. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
[TBL] [Abstract][Full Text] [Related]
24. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
[TBL] [Abstract][Full Text] [Related]
25. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.
Okubo K; Gotoh M; Shimada K; Ritsu M; Okuda M; Crawford B
Int Arch Allergy Immunol; 2005 Feb; 136(2):148-54. PubMed ID: 15650312
[TBL] [Abstract][Full Text] [Related]
26. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
Day JH; Briscoe MP; Welsh A; Smith JN; Clark A; Ellis AK; Mason J
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
[TBL] [Abstract][Full Text] [Related]
27. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
28. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
[TBL] [Abstract][Full Text] [Related]
29. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
30. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
31. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Simpson K; Jarvis B
Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
[TBL] [Abstract][Full Text] [Related]
32. Safety of fexofenadine in children treated for seasonal allergic rhinitis.
Graft DF; Bernstein DI; Goldsobel A; Meltzer EO; Portnoy J; Long J
Ann Allergy Asthma Immunol; 2001 Jul; 87(1):22-6. PubMed ID: 11476456
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.
Mösges R; Lehmacher W; Pasch N; Vent J
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572
[TBL] [Abstract][Full Text] [Related]
36. Loratadine provides early symptom control in seasonal allergic rhinitis.
Kaiser HB; Gopalan G; Chung W
Allergy Asthma Proc; 2008; 29(6):654-8. PubMed ID: 18831859
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.
Ngamphaiboon J; Direkwattanachai C; Visitsunthorn N; Vangveeravong M; Tiensuwan M
Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
40. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Milgrom H; Kittner B; Lanier R; Hampel FC
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
